乳腺保乳术后筛查钼靶AI分诊模拟研究
本研究回顾性分析1190例保乳术后女性的筛查钼靶,分别评估同侧与对侧乳房的AI分诊效能。同侧乳房三种模型癌症检出率均为6.6/1000、敏感度均为80%,AI可将77%检查判定为阴性。对侧乳房AI分诊在保持检出率与敏感度的同时降低了召回率。
要点
- 保乳术后同侧乳房的AI假阳性率较高,仍需放射科医师重点判读
- AI分诊可排除大量阴性钼靶检查而不降低同侧乳房检出率与敏感度
- 对侧乳房决策转诊AI模式的召回率低于单独AI模式且保持敏感度
核心结论
- AI分诊可排除保乳术后筛查钼靶中大量阴性检查,不降低癌症检出率或敏感度
- 同侧乳房AI-CAD假阳性率较高,放射科医师的专业判断仍不可替代
研究设计与样本
- 回顾性模拟研究,纳入2021年1月至5月连续1190例保乳术后女性筛查钼靶
- 使用商用AI-CAD系统模拟三种分诊模型:原始报告分诊、单独AI、决策转诊AI
- 同侧与对侧乳房分别分析,复发病灶以钼靶可见为标准
关键影像表现/征象
- 同侧乳房AI-CAD将77%检查判定为阴性,对侧乳房AI-CAD将90%检查判定为阴性
诊断标准与关键数值
- 同侧乳房三种模型CDR均为6.6/1000,敏感度均为80%,召回率分别为3.4%、23.0%、2.8%
- 对侧乳房原始报告CDR为1.8/1000,召回率1.9%,敏感度66.7%
- 对侧乳房单独AI的CDR为2.6/1000,召回率9.8%,敏感度100%;决策转诊AI召回率为2.0%
临床应用与阅片要点
- 对侧乳房可优先采用AI分诊排除阴性检查,降低不必要的召回
- 同侧乳房使用AI分诊时需警惕假阳性,放射科医师应保留最终判读权
局限性
- 回顾性单中心研究,样本量有限
- 研究为模拟分诊而非真实临床工作流中的前瞻性验证
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the diagnostic performance and potential of artificial intelligence (AI)-based triage for screening mammograms following breast-conserving therapy (BCT).
METHODS AND MATERIALS: In this retrospective study, consecutive post-BCT mammograms obtained between January and May 2021 were analyzed and divided into ipsilateral and contralateral breasts. Triage was simulated using three models with a commercial AI-based computer-aided detection (CAD), and outcomes were categorized as recall or no recall: (1) original report-based triage, (2) standalone AI, and (3) decision referral AI-triage. Cancer detection rate (CDR), recall rates, and diagnostic performance were evaluated.
RESULTS: A total of 1190 women were enrolled. For the ipsilateral breast, 10 mammography-visible recurrences were identified. All three models-original report, standalone AI, and decision referral AI-achieved equivalent CDR (6.6 per 1000) and sensitivity (80%), with recall rates of 3.4%, 23.0%, and 2.8%, respectively. AI-CAD classified 77% of examinations as negative without a reduction in CDR or sensitivity. For the contralateral breast, three recurrences were identified. The original report yielded a CDR of 1.8 per 1000, a recall rate of 1.9%, and 66.7% sensitivity. While AI-CAD triaged 90% of examinations as negative, standalone AI achieved a CDR of 2.6 per 1000, recall rate of 9.8%, and 100% sensitivity. Decision referral AI maintained CDR and sensitivity with a lower recall rate (2.0%).
CONCLUSIONS: Our simulation suggests that AI-based triage can exclude a substantial portion of negative mammograms following BCT without a reduction in CDR or sensitivity. Nonetheless, radiologist expertise remains crucial, particularly in interpreting the ipsilateral breast, given the higher false positive rate of AI-CAD.
引用
- Park, Kang, Kim, et al. Artificial intelligence-assisted triage of screening mammograms following breast-conserving therapy: a comparative simulation study. Radiol Med. 2026. PMID: 42726463. doi:10.1007/s11547-026-02243-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。